Q1 2023 Aurobindo Pharma Ltd Earnings Call Transcript
Ladies and gentlemen, welcome to quarter 1 FY '23 Earnings Conference Call of Aurobindo Pharma Limited. (Operator Instructions)
I now hand the conference over to Deepti Thakur. Thank you, and over to you.
Thank you, Aditya. Good morning, and a warm welcome to our first quarter FY '23 earnings call. I'm Deepti Thakur from Investor Relations team.
We hope you have received the quarter 1 FY '22 financials and the press release that was sent out yesterday. These are also available on our website.
I would like to introduce my senior management team today on the call with us, represented by Mr. P.V. Ram Prasad Reddy , Chairman, Aurobindo Pharma USA; Mr. K. Nithyananda Reddy, Vice Chairman and Managing Director of Aurobindo Pharma Limited, Mr. S. Subramanian, CFO; Mr. Sanjeev Dani, COO, Head Formulations, Aurobindo Pharma Limited; Mr. Yugandhar Puvvala, CEO of Eugia Pharma Specialities Limited; and Mr. Swami Iyer, CFO, Aurobindo Pharma USA.
We will begin the call with summary highlights from the management followed by an
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |